ELMD (Electromed, Inc.)
Insider Trading Activity
Every open-market purchase and sale reported by ELMD officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-03 | James L. Cunniff | CEO and President | F | — | — |
| 2026-09-03 | Bradley M. Nagel | Chief Financial Officer | MIXED | — | — |
| 2026-07-02 | Bradley M. Nagel | Chief Financial Officer | F | — | — |
| 2026-06-09 | James L. Cunniff | CEO and President | MIXED | — | — |
| 2026-06-08 | Bradley M. Nagel | Chief Financial Officer | MIXED | — | — |
| 2026-05-19 | KATHLEEN SKARVAN | Director | MIXED | — | — |
| 2025-12-03 | Andrea M. Walsh | Director | A | — | — |
| 2025-12-03 | Stan K. Erickson | Director | A | — | — |
| 2025-12-03 | Gregory Fluet | Director | A | — | — |
| 2025-12-03 | Joseph L. Galatowitsch | Director | A | — | — |
| 2025-12-03 | Andrew Summers | Director | A | — | — |
| 2025-12-03 | Kathleen A Tune | Director | A | — | — |
| 2025-12-03 | KATHLEEN SKARVAN | Director | A | — | — |
| 2025-09-12 | Andrew Summers | Director | Sell | — | — |
| 2025-09-04 | Bradley M. Nagel | Chief Financial Officer | MIXED | — | — |
| 2025-09-04 | James L. Cunniff | CEO and President | MIXED | — | — |
| 2025-02-24 | Andrew Summers | Director | Sell | — | — |
| 2025-02-19 | KATHLEEN SKARVAN | Director | MIXED | — | — |
| 2025-01-03 | James L. Cunniff | CEO and President | MIXED | — | — |
| 2024-12-06 | Andrew Summers | Director | Sell | — | — |
| 2024-12-04 | Andrew Summers | Director | Sell | — | — |
| 2024-12-03 | Gregory Fluet | Director | A | — | — |
| 2024-12-03 | Andrea M. Walsh | Director | A | — | — |
| 2024-12-03 | Kathleen A Tune | Director | A | — | — |
| 2024-12-03 | KATHLEEN SKARVAN | Director | A | — | — |
| 2024-12-03 | Andrew Summers | Director | A | — | — |
| 2024-12-03 | Joseph L. Galatowitsch | Director | A | — | — |
| 2024-12-03 | Stan K. Erickson | Director | A | — | — |
| 2024-11-20 | KATHLEEN SKARVAN | Director | Sell | — | — |
| 2024-10-02 | James L. Cunniff | CEO and President | MIXED | — | — |
| 2024-09-05 | James L. Cunniff | CEO and President | A | — | — |
| 2024-09-05 | Bradley M. Nagel | Chief Financial Officer | A | — | — |
| 2024-03-05 | James L. Cunniff | CEO and President | Buy | — | — |
| 2023-12-18 | Andrew Summers | Director | Buy | — | — |
| 2023-12-05 | Gregory Fluet | Director | A | — | — |
| 2023-12-05 | Kathleen A Tune | Director | A | — | — |
| 2023-12-05 | KATHLEEN SKARVAN | Director | A | — | — |
| 2023-12-05 | Andrea M. Walsh | Director | A | — | — |
| 2023-12-05 | Joseph L. Galatowitsch | Director | A | — | — |
| 2023-12-05 | Stan K. Erickson | Director | A | — | — |
| 2023-12-05 | Andrew Summers | Director | A | — | — |
| 2023-11-22 | James L. Cunniff | CEO and President | Buy | — | — |
| 2023-11-14 | Bradley M. Nagel | Chief Financial Officer | A | — | — |
| 2023-07-18 | KATHLEEN SKARVAN | Director | Sell | — | — |
| 2023-07-05 | James L. Cunniff | CEO and President | A | — | — |
| 2023-07-05 | Bradley M. Nagel | Chief Financial Officer | A | — | — |
| 2023-03-06 | KATHLEEN SKARVAN | President and CEO | MIXED | — | — |
| 2022-12-05 | Gregory Fluet | Director | A | — | — |
| 2022-12-05 | Andrea M. Walsh | Director | A | — | — |
| 2022-12-05 | Joseph L. Galatowitsch | Director | A | — | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| — | Director | 874,250 | — |
| — | Director | 587,901 | — |
| — | Director | 583,691 | — |
| — | Chief Executive Officer | 571,355 | — |
| — | Director | 490,750 | — |
| — | Director | 282,367 | — |
| — | Director | 194,994 | — |
| — | CEO and President | 145,080 | — |
| — | 10%+ Owner | 93,787 | — |
| — | Chief Financial Officer | 81,316 | — |
| — | Director | 50,000 | — |
| — | Director | 44,184 | — |
| — | Director | 40,317 | — |
| — | Chief Financial Officer | 32,000 | — |
| — | Director | 28,183 | — |
| — | Chief Financial Officer | 26,000 | — |
| — | Chief Financial Officer | 23,864 | — |
| — | Director | 21,000 | — |
| — | Director | 18,000 | — |
| — | Director | 15,000 | — |
| — | Director | 15,000 | — |
| — | Chief Commercial Officer | 12,900 | — |
| — | Chief Financial Officer | 5,600 | — |
| — | Director | 3,000 | — |
| — | Chief Operating Officer | 2,000 | — |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the ELMD quote page; the site-wide leaderboard is on the insider transactions hub.